In Silico Modeling of FDA-Approved Drugs for Discovery of Anti-Cancer Agents: A Drug-Repurposing Approach
Author:
Publisher
Elsevier
Reference160 articles.
1. Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer;Aftab;Cancer Research,2011
2. Recommendation techniques for drug-target interaction prediction and drug repositioning;Alaimo;Data Mining Techniques for the Life Sciences,2016
3. Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data;Aliper;Molecular Pharmaceutics,2016
4. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies;Allen;Lancet Oncology,2015
5. DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information;Amelio;Cell Death & Disease,2014
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Artificial Intelligence and Machine Learning in Drug Discovery;Advances in Healthcare Information Systems and Administration;2024-04-22
2. Probing the origins of programmed death ligand-1 inhibition by implementing machine learning-assisted sequential virtual screening techniques;Molecular Diversity;2023-07-20
3. Identification of a PD1/PD‐L1 inhibitor by structure‐based pharmacophore modelling, virtual screening, molecular docking and biological evaluation**;Molecular Informatics;2023-04-17
4. DDREL: From drug-drug relationships to drug repurposing;Intelligent Data Analysis;2022-01-14
5. Repurposing of FDA ‐approved drugs as inhibitors of sterol C‐24 methyltransferase of Leishmania donovani to fight against leishmaniasis;Drug Development Research;2021-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3